BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6233057)

  • 1. Observations on the radionuclide assessment of peritoneovenous shunt patency.
    Rosenthall L; Arzoumanian A; Hampson LG; Shennib H
    Clin Nucl Med; 1984 Apr; 9(4):227-35. PubMed ID: 6233057
    [No Abstract]   [Full Text] [Related]  

  • 2. Subintimal dissection of peritoneovenous shunt tubing. Demonstration with radionuclide study.
    Pezzuti RT; Clouse ME; Hill TC; Bothe A; Katz JF
    Clin Nucl Med; 1985 Jun; 10(6):395-7. PubMed ID: 4017389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transtubal scintigraphic assessment of patency of peritoneovenous shunts.
    Taggart GJ; Sullivan DC; Gusberg RJ; Conn HO
    Clin Nucl Med; 1981 Feb; 6(2):70-2. PubMed ID: 7460444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclide detection of peritoneovenous shunt patency.
    Gemmel F; Ravier M; Troisi R; Van Vlierberghe H; Lambert B; Renard V; Dierckx RA
    Clin Nucl Med; 2003 Dec; 28(12):986-7. PubMed ID: 14663324
    [No Abstract]   [Full Text] [Related]  

  • 5. The intraperitoneal use of Technetium Sulphur Colloid.
    Bolitho LE; Andrews JT; Lichtenstein M
    Australas Radiol; 1981 Jul; 25(2):159-61. PubMed ID: 7305786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydrothorax in ascites and its treatment with a peritoneovenous shunt].
    Kroon BB; van der Pompe WB
    Ned Tijdschr Geneeskd; 1984 Nov; 128(46):2165-8. PubMed ID: 6514032
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of peritoneovenous shunt patency with Tc-99m labeled microspheres.
    Madeddu G; D'Ovidio NG; Casu AR; Mura R; Costanza C; Lai N; LeVeen HH
    J Nucl Med; 1983 Apr; 24(4):302-7. PubMed ID: 6220137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of hydrothorax by intraperitoneal injection of technetium-99m MAA in the evaluation of peritoneovenous shunt patency.
    Stewart CA; Sakimura IT; Siegel ME
    Clin Nucl Med; 1986 Oct; 11(10):696-7. PubMed ID: 3769324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute quantification of pharmacokinetic distribution of RES colloids in individuals with normal liver function.
    Herzog H; Spohr G; Notohamiprodjo G; Feinendegen LE
    Nucl Med Commun; 1987 Mar; 8(3):157-75. PubMed ID: 3108736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m glucoheptonate as a scanning agent in hepatocellular carcinoma.
    Esser JD; Kew MC; Tobias M; Winterton R; Savitch I; Levin J
    Clin Nucl Med; 1985 Aug; 10(8):586-8. PubMed ID: 2994936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic perfusion index: colloid lung retention.
    Maughan J; Parkin A; Smith AH; Barker MC
    Nucl Med Commun; 1991 May; 12(5):465-6. PubMed ID: 2067752
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of radionuclides in the investigation of conjoined twins.
    Mann MD; Coutts JP; Kaschula RO; Fraser CB; Fisher RM; Cywes S
    J Nucl Med; 1983 Jun; 24(6):479-84. PubMed ID: 6222167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of LeVeen-shunt patency using Tc-99m labelled macroaggregated albumin.
    Adil AR; Waqar A
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):821-2. PubMed ID: 16398982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of peritoneovenous shunt patency by intraperitoneal Tc-99m macroaggregated albumin: clinical experience.
    Stewart CA; Sakimura IT; Applebaum DM; Siegel ME
    AJR Am J Roentgenol; 1986 Jul; 147(1):177-80. PubMed ID: 3487212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LeVeen shunt patency studies: clarification of scinigraphic findings.
    Singh A; Grossman ZD; McAfee JG; Thomas FD
    Clin Nucl Med; 1980 Mar; 5(3):106-8. PubMed ID: 6444562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A false-negative LeVeen shunt study.
    Williamson MR; Bundrick TJ
    Clin Nucl Med; 1985 Jul; 10(7):486-7. PubMed ID: 4028600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid.
    Green AM
    J Nucl Med; 1983 Oct; 24(10):971-2. PubMed ID: 6225843
    [No Abstract]   [Full Text] [Related]  

  • 18. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents.
    Bergqvist L; Strand SE; Persson BR
    Semin Nucl Med; 1983 Jan; 13(1):9-19. PubMed ID: 6220471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Tc-99m IDA hepatobiliary and Tc-99m colloid hepatic imaging in primary biliary cirrhosis.
    Aburano T; Yokoyama K; Shuke N; Kinuya S; Takayama T; Tonami N; Hisada K
    Clin Nucl Med; 1991 Jan; 16(1):4-9. PubMed ID: 1999054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
    Shuke N; Aburano T; Nakajima K; Yokoyama K; Sun BF; Matsuda H; Muramori A; Michigishi T; Tonami N; Hisada K
    Kaku Igaku; 1992 May; 29(5):573-84. PubMed ID: 1434071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.